Diabetes Care 27:530-537, 2004
© 2004 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe
The EURODIAB Prospective Complications Study
Sabita S. Soedamah-Muthu, PHD1,
Nish Chaturvedi, MD2,
Monika Toeller, MD3,
Barry Ferriss, MD4,
Paolo Reboldi, MD5,
Georges Michel, MD6,
Christos Manes, MD7 and
John H. Fuller, FRCP1 the EURODIAB Prospective Complications Study Group
1 Department of Epidemiology and Public-Health, Royal Free and University College London Medical School, London, U.K
2 International Centre for Circulatory Health and Department of Epidemiology and Public-Health, Imperial College London, London, U.K
3 Diabetes Research Institute, Heinrich-Heine University, Dusseldorf, Germany
4 Cork Regional Hospital, Cork, Ireland
5 Dipartimento di Medicina Interna e Scienze, Endocrine e Metaboliche, Perugia, Italy
6 Centre Hospitalier, Luxembourg, Luxemburg
7 General Hospital of Thessaloniki, Thessaloniki, Greece
Address correspondence and reprint requests to Sabita S. Soedamah-Muthu, EURODIAB Department of Epidemiology and Public-Health Royal Free and University College London Medical School 1-19 Torrington Place, London, WC1E 6BT U.K.. E-mail: sabita{at}public-health.ucl.ac.uk
OBJECTIVEThe goal of the study was to examine risk factors in the prediction of coronary heart disease (CHD) and differences in men and women in the EURODIAB Prospective Complications Study.
RESEARCH DESIGN AND METHODSBaseline risk factors and CHD at follow-up were assessed in 2,329 type 1 diabetic patients without prior CHD. CHD was defined as physician-diagnosed myocardial infarction, angina pectoris, coronary artery bypass graft surgery, and/or Minnesota-coded ischemic electrocardiograms or fatal CHD.
RESULTSThere were 151 patients who developed CHD, and the 7-year incidence rate was 8.0 (per 1,000 person-years) in men and 10.2 in women. After adjustment for age and/or duration of diabetes, the following risk factors were related to CHD in men: age, GHb, waist-to-hip ratio (WHR), HDL cholesterol, smoking, albumin excretion rate (AER), and autonomic neuropathy. The following risk factors were related to CHD in women: age, systolic blood pressure (BP), fasting triglycerides, AER, and retinopathy. Multivariate standardized Cox proportional hazards models showed that age (hazard ratio 1.5), AER (1.3 in men and 1.6 in women), WHR (1.3 in men), smoking (1.5 in men), fasting triglycerides (1.3 in women) or HDL cholesterol (0.74 in women), and systolic BP (1.3 in women) were predictors of CHD.
CONCLUSIONSThis study supports the evidence for a strong predictive role of baseline albuminuria in the pathogenesis of CHD in type 1 diabetes. Furthermore, sex-specific risk factors such as systolic BP, fasting triglycerides (or HDL cholesterol), and WHR were found to be important in the development of CHD.
Abbreviations: AER, albumin excretion rate BP, blood pressure CHD, coronary heart disease ECG, electrocardiogram EDC, epidemiology of diabetes complications FTG, fasting triglycerides MI, myocardial infarction PCS, Prospective Complications Study WHR, waist-to-hip ratio

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Dickinson, T. Rogers, B. Kasiske, S. Bertog, G. Tadros, J. Malik, R. Wilson, and C. Panetta
Coronary Artery Disease in Young Women and Men With Long-Standing Insulin-dependent Diabetes
Angiology,
March 1, 2008;
59(1):
9 - 15.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohno, S. Takamoto, and N. Motomura
Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective
Ann. Thorac. Surg.,
February 1, 2008;
85(2):
681 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Maahs, L. G. Ogden, A. Kretowski, J. K. Snell-Bergeon, G. L. Kinney, T. Berl, and M. Rewers
Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes
Diabetes,
November 1, 2007;
56(11):
2774 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Galler, G. Gelbrich, J. Kratzsch, N. Noack, T. Kapellen, and W. Kiess
Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study
Eur. J. Endocrinol.,
October 1, 2007;
157(4):
481 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shankar, R. Klein, B. E. K. Klein, and S. E. Moss
Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 Diabetes
Am. J. Epidemiol.,
August 15, 2007;
166(4):
393 - 402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Herbst, O. Kordonouri, K. O. Schwab, F. Schmidt, R. W. Holl, and on behalf of the DPV Initiative of the German Work
Impact of Physical Activity on Cardiovascular Risk Factors in Children With Type 1 Diabetes: A multicenter study of 23,251 patients
Diabetes Care,
August 1, 2007;
30(8):
2098 - 2100.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Giunti, G. Bruno, E. Lillaz, G. Gruden, V. Lolli, N. Chaturvedi, J. H. Fuller, M. Veglio, P. Cavallo-Perin, and The EURODIAB IDDM Complications Study Group
Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes: The EURODIAB Prospective Complications Study
Diabetes Care,
August 1, 2007;
30(8):
2057 - 2063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto
Type 1 diabetes and coronary artery disease.
Diabetes Care,
November 1, 2006;
29(11):
2528 - 2538.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Costacou, Y. Chang, R. E. Ferrell, and T. J. Orchard
Identifying Genetic Susceptibilities to Diabetes-related Complications among Individuals at Low Risk of Complications: An Application of Tree-Structured Survival Analysis
Am. J. Epidemiol.,
November 1, 2006;
164(9):
862 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Maahs and M. Rewers
Mortality and Renal Disease in Type 1 Diabetes Mellitus--Progress Made, More to Be Done.
J. Clin. Endocrinol. Metab.,
October 1, 2006;
91(10):
3757 - 3759.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri, P. Beyer, R. W. Holl, and on behalf of the DPV Initiative of the German Work
Spectrum and Prevalence of Atherogenic Risk Factors in 27,358 Children, Adolescents, and Young Adults With Type 1 Diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)
Diabetes Care,
February 1, 2006;
29(2):
218 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Libby, D. M. Nathan, K. Abraham, J. D. Brunzell, J. E. Fradkin, S. M. Haffner, W. Hsueh, M. Rewers, B. T. Roberts, P. J. Savage, et al.
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus
Circulation,
June 28, 2005;
111(25):
3489 - 3493.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. van Hecke, J. M. Dekker, C. D.A. Stehouwer, B. C.P. Polak, J. H. Fuller, A. K. Sjolie, A. Kofinis, R. Rottiers, M. Porta, and N. Chaturvedi
Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence: The EURODIAB Prospective Complications Study
Diabetes Care,
June 1, 2005;
28(6):
1383 - 1389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tesfaye, N. Chaturvedi, S. E.M. Eaton, J. D. Ward, C. Manes, C. Ionescu-Tirgoviste, D. R. Witte, J. H. Fuller, and the EURODIAB Prospective Complications Study Group
Vascular Risk Factors and Diabetic Neuropathy
N. Engl. J. Med.,
January 27, 2005;
352(4):
341 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|